CCAB Partners With ImmunoBiochem as it Launches New Co-Development Strategy to Advance Early-Stage Biotech Companies Read more
Invitation from Dr James Legg, Vice President R&D at Crescendo Biologics, Chair of this year’s Immuno-Oncology Conference in London Read more
Regeneron and Teva Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip Read more
Eisai And Merck Announce FDA Approval Of LENVIMA Capsules For Treatment Of Unresectable HCC Read more
BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza Read more